DE60018967D1 - Inierzierbare valnemulin formulierung - Google Patents

Inierzierbare valnemulin formulierung

Info

Publication number
DE60018967D1
DE60018967D1 DE60018967T DE60018967T DE60018967D1 DE 60018967 D1 DE60018967 D1 DE 60018967D1 DE 60018967 T DE60018967 T DE 60018967T DE 60018967 T DE60018967 T DE 60018967T DE 60018967 D1 DE60018967 D1 DE 60018967D1
Authority
DE
Germany
Prior art keywords
inminable
valnemulin
formulation
valnemulin formulation
inminable valnemulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60018967T
Other languages
English (en)
Other versions
DE60018967T2 (de
Inventor
Kurt Koller
Franz Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE60018967D1 publication Critical patent/DE60018967D1/de
Publication of DE60018967T2 publication Critical patent/DE60018967T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60018967T 1999-12-09 2000-12-07 Inierzierbare valnemulin formulierung Expired - Lifetime DE60018967T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99811128 1999-12-09
EP99811128 1999-12-09
PCT/EP2000/012346 WO2001041758A2 (en) 1999-12-09 2000-12-07 Valnemulin formulation

Publications (2)

Publication Number Publication Date
DE60018967D1 true DE60018967D1 (de) 2005-04-28
DE60018967T2 DE60018967T2 (de) 2006-03-23

Family

ID=8243176

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60018967T Expired - Lifetime DE60018967T2 (de) 1999-12-09 2000-12-07 Inierzierbare valnemulin formulierung

Country Status (19)

Country Link
US (1) US6284792B1 (de)
EP (1) EP1235566B1 (de)
JP (1) JP3864090B2 (de)
KR (1) KR100491464B1 (de)
CN (1) CN1188122C (de)
AR (1) AR029777A1 (de)
AT (1) ATE291422T1 (de)
AU (1) AU769857B2 (de)
BR (1) BR0016262B1 (de)
CA (1) CA2390047C (de)
DE (1) DE60018967T2 (de)
DK (1) DK1235566T3 (de)
ES (1) ES2240232T3 (de)
MX (1) MXPA02005705A (de)
PT (1) PT1235566E (de)
RU (1) RU2270676C2 (de)
TW (1) TWI228048B (de)
WO (1) WO2001041758A2 (de)
ZA (1) ZA200204460B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5390081A1 (es) * 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
US6918561B2 (en) * 2002-10-31 2005-07-19 Yon So Chong Shell assembly for winding tire cord strip or belt cord strip
CN101744799B (zh) * 2008-12-12 2012-01-11 北京大北农科技集团股份有限公司 一种兽用沃尼妙林及其盐的脂质体新剂型及其制备方法
CN101947203A (zh) * 2010-10-14 2011-01-19 郑州后羿制药有限公司 一种兽用盐酸沃尼妙林乳剂及其制备方法
CN103288694B (zh) * 2013-06-28 2015-06-17 宁夏泰瑞制药股份有限公司 一种截短侧耳素类合成衍生物盐的晶体制备方法
CN103483232B (zh) * 2013-09-25 2015-05-13 宁夏泰瑞制药股份有限公司 一种盐酸沃尼妙林的精制方法
CN103520099A (zh) * 2013-10-30 2014-01-22 王玉万 含有效成份为沃尼妙林的长效注射剂
CN103705454B (zh) * 2014-01-07 2016-08-31 王玉万 含盐酸沃尼妙林/泊洛沙姆407的油质注射剂
CN104689324A (zh) * 2014-07-30 2015-06-10 王玉万 含亲水性治疗药物可乳化油质注射剂的制备方法
CN104311464A (zh) * 2014-09-15 2015-01-28 河北威远动物药业有限公司 一种兽用沃尼妙林的制备方法
KR102098289B1 (ko) * 2018-04-11 2020-04-07 경북대학교 산학협력단 발네물린을 유효성분으로 함유하는 골 질환 예방 또는 치료용 조성물
CN108635333B (zh) * 2018-07-10 2021-10-01 四川通达动物保健科技有限公司 一种盐酸沃尼妙林冻干粉针剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
EP1235566A2 (de) 2002-09-04
JP2003516352A (ja) 2003-05-13
CA2390047C (en) 2010-03-16
DK1235566T3 (da) 2005-06-20
KR100491464B1 (ko) 2005-05-25
MXPA02005705A (es) 2002-09-18
US6284792B1 (en) 2001-09-04
AU769857B2 (en) 2004-02-05
PT1235566E (pt) 2005-08-31
DE60018967T2 (de) 2006-03-23
US20010021693A1 (en) 2001-09-13
KR20020064335A (ko) 2002-08-07
BR0016262B1 (pt) 2014-10-21
AR029777A1 (es) 2003-07-16
CN1188122C (zh) 2005-02-09
WO2001041758A8 (en) 2002-08-29
CA2390047A1 (en) 2001-06-14
ATE291422T1 (de) 2005-04-15
EP1235566B1 (de) 2005-03-23
AU3007701A (en) 2001-06-18
CN1409631A (zh) 2003-04-09
WO2001041758A3 (en) 2002-03-07
TWI228048B (en) 2005-02-21
JP3864090B2 (ja) 2006-12-27
ZA200204460B (en) 2003-09-03
RU2270676C2 (ru) 2006-02-27
ES2240232T3 (es) 2005-10-16
WO2001041758A2 (en) 2001-06-14
BR0016262A (pt) 2002-08-13

Similar Documents

Publication Publication Date Title
NO2019016I1 (no) dasatinib
DK1250138T3 (da) Fulvestrantformulering
DE1235487T1 (de) Ernaehrungszusammensetzung
IS6120A (is) Lyfjablanda
ID28698A (id) Formulasi antiparasit
ID29635A (id) Formulasi mikrokapsul
AR023440A1 (es) Composiciones antitranspirantes
PT1242087E (pt) Composicoes farmaceuticas
DE60005321D1 (de) Agrochemische formulierungen
DE59907942D1 (de) Vormischbrenner
ID29785A (id) Komposisi-komposisi sampo
DE60007731D1 (de) Schweisshemmende zusammensetzungen
IS6398A (is) Lyfjablöndur
DE69943245D1 (de) Gaserzeugende zusammensetzung
ID27655A (id) Formulasi mikrokapsul
NO20020151D0 (no) Veksthormonformuleringer
PT1239832E (pt) Composicoes farmaceuticas
DE60018967D1 (de) Inierzierbare valnemulin formulierung
ATE250092T1 (de) Polyolformulierung
ID30032A (id) Formulasi farmasi
DE59909531D1 (de) Vormischbrenner
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
AR025867A1 (es) Formulacion portasdora farmaceutica
DE60010151D1 (de) Vormischbrenner
ID27329A (id) Komposisi penghambat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336